XHKG2293
Market cap35mUSD
Jan 07, Last price
0.69HKD
1D
1.47%
1Q
7.81%
Jan 2017
-47.73%
IPO
-67.45%
Name
Bamboos Health Care Holdings Ltd
Chart & Performance
Profile
Bamboos Health Care Holdings Limited, an investment holding company, provides healthcare staffing solutions in Hong Kong. It offers healthcare institution support and private nursing solutions. The company also provides marketing and consulting services; and technology promotion and application services, as well as operates aesthetic clinics. It serves individuals and institutional clients, including hospitals, social service organizations, and clinics. The company was founded in 2009 and is headquartered in Tsim Sha Tsui, Hong Kong.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 94,787 -25.84% | 127,814 -9.61% | 141,398 27.61% | |||||||
Cost of revenue | 14,456 | 55,497 | 56,282 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 80,331 | 72,317 | 85,116 | |||||||
NOPBT Margin | 84.75% | 56.58% | 60.20% | |||||||
Operating Taxes | 8,310 | 11,755 | 13,817 | |||||||
Tax Rate | 10.34% | 16.25% | 16.23% | |||||||
NOPAT | 72,021 | 60,562 | 71,299 | |||||||
Net income | 30,919 -34.10% | 46,919 -19.96% | 58,620 -3.94% | |||||||
Dividends | (35,123) | (35,000) | (40,000) | |||||||
Dividend yield | 14.16% | 11.67% | 12.05% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 63,730 | 67,623 | 68,958 | |||||||
Long-term debt | 611 | 1,226 | 1,446 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | (1) | (722) | ||||||||
Net debt | (37,488) | (51,196) | (45,331) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 36,566 | 41,936 | 116,111 | |||||||
CAPEX | (1,662) | (261) | (15,742) | |||||||
Cash from investing activities | (7,091) | 6,917 | (111,630) | |||||||
Cash from financing activities | (39,715) | (41,797) | 25,150 | |||||||
FCF | 60,316 | 66,165 | (47,309) | |||||||
Balance | ||||||||||
Cash | 81,147 | 103,974 | 93,833 | |||||||
Long term investments | 20,682 | 16,071 | 21,902 | |||||||
Excess cash | 97,090 | 113,654 | 108,665 | |||||||
Stockholders' equity | 177,383 | 183,197 | 171,480 | |||||||
Invested Capital | 184,966 | 163,748 | 150,579 | |||||||
ROIC | 41.31% | 38.53% | 78.12% | |||||||
ROCE | 28.48% | 26.07% | 32.83% | |||||||
EV | ||||||||||
Common stock shares outstanding | 400,137 | 400,000 | 400,000 | |||||||
Price | 0.62 -17.33% | 0.75 -9.64% | 0.83 3.75% | |||||||
Market cap | 248,085 -17.30% | 300,000 -9.64% | 332,000 3.75% | |||||||
EV | 210,597 | 248,804 | 286,669 | |||||||
EBITDA | 90,466 | 82,309 | 92,805 | |||||||
EV/EBITDA | 2.33 | 3.02 | 3.09 | |||||||
Interest | 3,394 | 2,390 | 1,192 | |||||||
Interest/NOPBT | 4.23% | 3.30% | 1.40% |